The PK/PD Study of SHR0532 Tablets in Healthy Subjects

Summary

In the last four decades, several classes of diuretics have been the first line option for the therapy of widespread hypertension. However, all the classes of diuretics cause alteration of potassium homeostasis. The primary objective of this study is to assess the safety and tolerability of SHR0532 tablets in healthy subjects. In addition, this study will provide information on Pharmacokinetics and Pharmacodynamics of SHR0532 tablets in healthy subjects.

Timeline

Start

2018-08-24

Primary completion

2018-12-15

Completion

2019-04-30

Drugs

Indications